Back
Kura Oncology, Inc. KURA · Insights
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatmen... Price7.57
Market Cap673.43 M
Float86.49 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro